INTRODUCTION
Nephrotic syndrome (NS) is a common chronic disorder. characterized by alterations of permeability at the glomerular capillary wall, resulting in its inability to restrict the urinary loss of protein' I t.
Chronic kidney -disease (CKD) has recently assumed epidemic proportion becoming a troubling emerging cause of morbidity, especially if it progresses to terminal stage end stage renal disease f`t .
The annual incidence of nephrotic syndrome in most countries in the Western hemisphere is estimated to range from 2-7 new cases per 100,000 children, and the prevalence from 12-16 per 100,000 children ( 3) .
The reported prevalence of chronic renal failure in Egypt is 225 per million populations ( ' 4) . Specifіc laboratory investigations included both serum and urinary level of NGAL using enzyme linked-immunosorbent assay (E L ISA).
The Quantikine NGAL kit is a solidphase sandwich enzyme linked-immunosorbent assay. A monoclonal antibody specitїc for NGA1. has been pre-coated onto a microplate. Standards and samples were pipetted into the wells and any NGAI, present was bound by the immobilized antibody. After washing away any unbound substances, an enzyme-linked monoclonal antibody specific for NGAI, was added to the wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate solution was added to the wells and color developed in proportion to the amount of NGAL bound in the initial step. The color development was stopped and the intensity of the color was measured.
The study was approved by the Ethical Committee of Faculty of Medicine, BeniSuef University and informed consent was obtained from all the participants care givers.
Statistical methods:
For statistical analysis, Statistical Control group: Oliguria and edema before treatment which improved after it. Cholesterol, urea and K were significantly higher and albumin was significantly lower in NS patients versus control. There was no significant difference between two groups as regards Na, creatinine and eGFR. Table ( 2) demonstrates that sNGAL was significantly higher in both SDNS and SSNS groups versus the control group and also SUNS group versus SSNS group (95.7 f 29.9 ng/ml) and (73.4 + 16.4 ng/m1) versus (45.6-i f 15.7 ng/m1) and also (95.7 f 29.9 ng/m1) versus (73.4f 16.4 ng/m1) (p 0.001. 0.001 and , 0.027 respectively). uNGAI. was significantly higher in SDNS group versus the control group (6.7 f 5.2 ng/ml) versus (2.9 f 1.1 ng/m1) while between SSNS group; versus control group and SЛNS group versus SSNS group uNGAI. showed higher concentration but it didn't reach statistical significance (p 0.009, 0.055, 0.637 respectively).
Patients group was subdivided into proteinuric (8 patients) and non proteinuric (22 patients) groups according to presence and absence of urine protein respectively. 1.1 ng/ml) (p 0.001 and 0.011 respectively).
The non-proteinuric group showed significantly higher concentration versus control group as regards sNGAL (82.3 23.7 ng/ml) versus (45.6 15.7 ng/ml) and uNGAI_ (6.6 6.0 ng/ml) versus (2.9 1.1 ng/ml) (p = 0.001 and 0.023 respectively).
Although the proteinuric group showed higher concentration than the non-proteinuric group as regards sNGAL, the difference was not significant. (6) show that sNGAL at a concentration of 56.1 ng/ml showed the best cutoff value where the sensitivity was 86.7% and the specificity was 90% calculated by the ROC curves.
At a concentration of 3 ng/ml, uNGAL, had the best cutoff value where the sensitivity was 86.7% and the specificity was 80%.
Area under the ROC curve for sNGAL was 0.9 indicating best performance followed by 0.8 value for uNGAL (Fig. 6 ).
DISCUSSION
Neutrophil gelatinase-associated lipocalmn expression is rapidly induced in the nephron in response to renal epithelial injury. NGAL levels are predictive of the onset of acute renal injury and also the serious exacerbation of unstable nephropathy. Also, NGAL may be involved in the pathophysiological process of chronic renal conditionst 10).
In our study, sNGAL and uNGAL showed significantly higher concentration in chronic relapsing NS group versus control group (p = 0.001, 0.024 respectively). Although, there was no significant difference between NS patients and the normal control regarding eGFR or creatinine.
This shows that with normal eGFR in chronic kidney diseases such as chronic nephrotic syndrome, the ongoing renal pathology needs to be monitored with more sensitive renal markers.
NGAL is one of the most promising biomarkers that are able to reveal the onset of acute kidney injury. However, in certain studies on chronic kidney diseases like ours, it showed that it would be beneficial to predict CKD progression.
Bolignano et al., reported that in subjects affected by non-terminal CKD of various etiology the mean uNGAL concentrations were higher in CKD patients having polycystic kidney, disease and glomerulonephritis than normal control (p = 0.0l )( 11).
Another study confirmed these results and reported that subjects with CKD due to chronic glomerulonephritis had higher mean uNGAL concentrations than normal controls (p = 0.01) (
').
More recently, Malys/ko, in 2010 and Shavit et al, in 2011 reported that sNGAL was significantly higher in patients with CKD and stated that the NGAL is a highly sensitive marker of renal injury as it is also elevated in CKD and it might perform better in children than in adults, probably because they have less or even no co morbidities '3.14) Soni et al., reported that uNGAL measurement is probably more reflective of local renal injury and is non-invasive in nature reducing the need for frequent blood sampling and handling of blood lines in critically ill patіents (б) .
Kuwabara et al., reported that patients
with nephrotic syndrome or interstitial nephritis had markedly elevated uNGAL levels that decreased in response to successful treatment ( 15) . According to our findings concerning sNGAL and uNGAL which showed significantly higher concentrations than control, and supported by similar results in previously mentioned research, we can assume that in patients with CKD, NGAL closely reflects the entity of renal impairment and represents a strong and independent risk marker for progression of CKD and that NGAL may become one of the most promising next generation biomarkers in clinical nephrology. Whether one measurement of sNGAL or uNGAL is useful over the other can be known after wider clinical application of these tests. It is also possible that together they provide complementary information.
Our study reported that sNGAL showed significantly higher concentration in the SDNS group versus the control group.
SSNS group versus control group and
We found that uNGAL showed significantly higher concentration in the SDNS group versus the control group while between SSNS group and the control group, SDNS group and the SSNS group uNGAL, showed a higher concentration but it didn't reach statistical significance (p = 0.009, 0.055, 0.637 respectively).
In the proteinuric group versus the control group, higher concentrations of both sNGAL and uNGAL were found (p 0.001, 0.011 respectively).
In agreement with our study is Bolignano et al., who reported that in patients with proteinuria, uNGAL concentrations were significantly higher than in controls
The authors suggested that correlation between uNGAL and the degree of proteinuria can be attributed to a response of such tissue to the condition of chronic tubular stress. They reported that it is wellknown. in fact, that a persistent macroproteinuria itself constitutes a factor of progressive renal damage caused by the toxicity of the plasmatic protein on tubular renal cells, particularly proximal ones. Such toxicity promotes apoptosis. The increased production of NGAL by tubular cells could in this context constitute a compensatory mechanism, with defensive intent, based on the inhibition of apoptosis processes by this protein, but it should not be excluded that the same cell damage from chronic tubular injury causes increased urinary excretion of NGAL° 1 '.
In our study, sNGAL showed significance positive correlation with Scrum creatinine (r == 0.556, p = 0.017) in SDNS group.
We found that eGFR showed inverse correlation with sNGAL in NS patients and with sNGAL and uNGAL in SDNS group. Yet, it didn't reach statistical significance (r =---0.154, p --0.417), (r = -0.448, p 0.062) and (r -0.001, p --0.996) respectively.
Several studies were in agreement with ours and reported that UNCIAL or sNGAL concentrations were significantly correlated with either serum creatinine concentrations, еС FR or proteinuria An interesting theory was proposed by Mori and Nakao and might explain the relationship between NGAI. and GFR, suggesting that the increase in NGA1, is not just the passive consequence of a reduced renal clearance. This hypothesis, called the "forest Fire theory". assumes that the increase in NGAL in chronic kidney disease "forest fire" is the consequence of a sustained production by "inflamed" but vital tubular cells, whereas the rise in serum creatinine and the contraction of GFR are the mere passive result of a general loss of functional cells or nephrons 1 ' 01 .
Our findings of a significantly higher frequency as regards urine protein in NS compared with the control group, positive correlation between sNGAL and creatinine and negative correlation between both sNGAL and uNGAI., versus eGFR among patients which were documented by similar results in other studies suggest that NGAI, levels clearly correlated with severity of renal impairment probably expressing the degree of active damage underlying the chronic condition and that NGAL should be investigated as an early marker of kidney function impairment in patients with CKD. From this point of view, NGAL would represent a real-time indicator of how much active kidney damage exists within the overall condition of chronic renal impairment.
Arena et al., reported that NGAI, levels, clearly correlated with the severity of renal impairment and probably expresses the degree of active damage underlying the chronic conditionl 10) .
In our study, we found that sNGAL at a concentration of 56.1 ng/ml showed the best cutoff value where the sensitivity was 86.7% and the specificity was 90% calculated by the ROC curve. While at a concentration of 3 ngiml, uNGA1, had the best cutoff value where the sensitivity was 86.7% and the specilkity was 80%. Bolignano et al., reported that for sNGAL the best cut-off level was found to be 435 mg/ml (sensitivity 83.9%, specificity 53.8%), whereas for uNGAL it was 231 mg/ml (sensitivity 80.6%, specificity 73.8%) (2) .
Conclusion and Recommendations:
Serum and urinary NGAL are useful markers of progression of CKD in chronic nephrotic syndrome. They could provide a good reflection of the severity of the renal disease as sNGAL was found to be significantly higher in SDNS versus SSNS. It might reflect also the degree of response to steroid treatment.
Further studies are needed especially for a longer observation period to confirm our findings and to determine whether therapeutic measures targeting NGAL balance would be helpful in delaying the progression of CКD.
